Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidem...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/23/6999 |
_version_ | 1797462932387266560 |
---|---|
author | Ana I. Molina-Ramos Elisabeth Gómez-Moyano Jorge Rodríguez-Capitán María Angullo-Gómez Patricia Gallardo-Jiménez Iván Pérez de Pedro Lucía Valiente de Santis Beatriz Pérez-Villardón Isabel Piñero-Uribe Javier Mora-Robles Víctor Manuel Becerra-Muñoz Manuel Jiménez-Navarro |
author_facet | Ana I. Molina-Ramos Elisabeth Gómez-Moyano Jorge Rodríguez-Capitán María Angullo-Gómez Patricia Gallardo-Jiménez Iván Pérez de Pedro Lucía Valiente de Santis Beatriz Pérez-Villardón Isabel Piñero-Uribe Javier Mora-Robles Víctor Manuel Becerra-Muñoz Manuel Jiménez-Navarro |
author_sort | Ana I. Molina-Ramos |
collection | DOAJ |
description | The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines. |
first_indexed | 2024-03-09T17:43:32Z |
format | Article |
id | doaj.art-60998c88192146cf91389365af855300 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-09T17:43:32Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-60998c88192146cf91389365af8553002023-11-24T11:21:13ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011123699910.3390/jcm11236999Myocarditis Related to COVID-19 and SARS-CoV-2 VaccinationAna I. Molina-Ramos0Elisabeth Gómez-Moyano1Jorge Rodríguez-Capitán2María Angullo-Gómez3Patricia Gallardo-Jiménez4Iván Pérez de Pedro5Lucía Valiente de Santis6Beatriz Pérez-Villardón7Isabel Piñero-Uribe8Javier Mora-Robles9Víctor Manuel Becerra-Muñoz10Manuel Jiménez-Navarro11Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainDermatology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainInternal Medicine Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainInternal Medicine Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainInfectious Diseases Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainThe coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.https://www.mdpi.com/2077-0383/11/23/6999COVID-19myocarditismRNA vaccines |
spellingShingle | Ana I. Molina-Ramos Elisabeth Gómez-Moyano Jorge Rodríguez-Capitán María Angullo-Gómez Patricia Gallardo-Jiménez Iván Pérez de Pedro Lucía Valiente de Santis Beatriz Pérez-Villardón Isabel Piñero-Uribe Javier Mora-Robles Víctor Manuel Becerra-Muñoz Manuel Jiménez-Navarro Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination Journal of Clinical Medicine COVID-19 myocarditis mRNA vaccines |
title | Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination |
title_full | Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination |
title_fullStr | Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination |
title_full_unstemmed | Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination |
title_short | Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination |
title_sort | myocarditis related to covid 19 and sars cov 2 vaccination |
topic | COVID-19 myocarditis mRNA vaccines |
url | https://www.mdpi.com/2077-0383/11/23/6999 |
work_keys_str_mv | AT anaimolinaramos myocarditisrelatedtocovid19andsarscov2vaccination AT elisabethgomezmoyano myocarditisrelatedtocovid19andsarscov2vaccination AT jorgerodriguezcapitan myocarditisrelatedtocovid19andsarscov2vaccination AT mariaangullogomez myocarditisrelatedtocovid19andsarscov2vaccination AT patriciagallardojimenez myocarditisrelatedtocovid19andsarscov2vaccination AT ivanperezdepedro myocarditisrelatedtocovid19andsarscov2vaccination AT luciavalientedesantis myocarditisrelatedtocovid19andsarscov2vaccination AT beatrizperezvillardon myocarditisrelatedtocovid19andsarscov2vaccination AT isabelpinerouribe myocarditisrelatedtocovid19andsarscov2vaccination AT javiermorarobles myocarditisrelatedtocovid19andsarscov2vaccination AT victormanuelbecerramunoz myocarditisrelatedtocovid19andsarscov2vaccination AT manueljimeneznavarro myocarditisrelatedtocovid19andsarscov2vaccination |